Krystek S R, Hunt J T, Stein P D, Stouch T R
Department of Macromolecular Modeling, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000.
J Med Chem. 1995 Feb 17;38(4):659-68. doi: 10.1021/jm00004a012.
A three-dimensional quantitative structure-activity relationship (QSAR) using steric and electrostatic fields (comparative molecular field analysis, CoMFA) applied to 36 aryl sulfonamides assayed for endothelin receptor subtype-A (ETA) antagonism provided high cross-validation correlations (0.7) and showed promising predictive ability. The results were validated through trials using scrambled activities as well as trials using scrambled orientation of molecules. CoMFA was used to discriminate between alternate hypothetical biologically active conformations. CoMFA was also used to discriminate between two different molecular superpositions representing possible positioning within the receptor binding site. The preferred superposition supports hypotheses that suggest Tyr129 in the ETA receptor as a key residue for antagonist binding. Significant CoMFA results were obtained when crudely optimized geometries and simple charge schemes were used. The results improved on refinement, most substantially with refinement of the atomic charges.
运用空间场和静电场的三维定量构效关系(QSAR,即比较分子场分析,CoMFA),对36种用于检测内皮素A受体(ETA)拮抗活性的芳基磺酰胺进行分析,得到了较高的交叉验证相关性(0.7),并显示出良好的预测能力。通过使用随机活性以及分子随机取向的试验对结果进行了验证。CoMFA用于区分不同的假设生物活性构象。CoMFA还用于区分代表受体结合位点可能定位的两种不同分子叠加方式。优选的叠加方式支持了一些假说,这些假说认为ETA受体中的Tyr129是拮抗剂结合的关键残基。当使用粗略优化的几何结构和简单电荷方案时,获得了显著的CoMFA结果。经过优化后结果得到改善,其中原子电荷的优化最为显著。